Company Filing History:
Years Active: 2020
Title: Meiqi Zhang: Innovator in Aza-Tryptanthrin Derivatives
Introduction
Meiqi Zhang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications. His work focuses on the inhibition of specific enzymes that play a crucial role in various diseases.
Latest Patents
Meiqi Zhang holds a patent for the "Use of aza-tryptanthrin derivatives as inhibitors of IDO1 and/or TDO." This invention discloses the use of aza-tryptanthrin derivatives as inhibitors of indoleamine-2,3-dioxygenase 1 (IDO1) and/or tryptophan-2,3-dioxygenase (TDO). The compounds represented by the general Formula (I) have demonstrated inhibitory effects on these enzymes. They can be utilized for treating diseases characterized by IDO1 and/or TDO-mediated tryptophan metabolism, including tumors, autoimmune diseases, infectious diseases, Alzheimer's disease, depression, and anxiety. Meiqi Zhang has 1 patent to his name.
Career Highlights
Meiqi Zhang is affiliated with Peking University, where he conducts research and develops innovative solutions in the field of biochemistry. His academic background and research experience have positioned him as a key figure in his area of expertise.
Collaborations
Some of his notable coworkers include Xiangbao Meng and Yu Chen. Their collaborative efforts contribute to the advancement of research and innovation in their field.
Conclusion
Meiqi Zhang is a dedicated inventor whose work on aza-tryptanthrin derivatives has the potential to impact the treatment of various diseases. His contributions to medicinal chemistry highlight the importance of innovation in addressing health challenges.